Добавил:
Sekretar
kiopkiopkiop18@yandex.ru
t.me/Prokururor I Вовсе не секретарь, но почту проверяю
Опубликованный материал нарушает ваши авторские права? Сообщите нам.
Вуз:
Предмет:
Файл:Ординатура / Хирургия / Библиотека им академика М.И. Перельмана / Книга_6035_Библиотеки_им_академика_М_И_Перельмана.pdf
X
- •About the Editor
- •Contents
- •Contributors
- •Abbreviations
- •Preface
- •1. Natural Products as Drug Candidates
- •1.1 Introduction
- •1.2 An array of natural products
- •1.2.1 Plant-derived natural products
- •1.2.2 Microbial natural products
- •1.3 Importance of analytical techniques
- •1.3.1 A glance at extraction techniques
- •1.3.2 Microbial culturing techniques
- •1.3.3 Outlook and perspectives in nanoparticles
- •1.4 Natural products as a guide in drug design and synthesis
- •1.5 Natural products as promising drug candidates
- •1.5.1 Antiviral drug candidates
- •1.5.2 Antiparasitic drug candidates
- •1.5.3 Neuroprotective agents
- •1.6 Conclusion
- •Keywords
- •References
- •2. Traditional Knowledge for Drug Discovery
- •2.1 Introduction
- •2.2 Databases on indian remedial flora, indigenous medicines, and phytochemicals
- •2.2.1 Cultural preservation
- •2.2.2 Sustainable practices
- •2.2.3 Biodiversity conservation
- •2.2.4 Health and medicine
- •2.2.5 Climate change adaptation
- •2.2.6 Interconnectedness and wisdom
- •2.3 History of traditional knowledge
- •2.3.1 Indigenous healing practices
- •2.3.2 Aboriginal dreamtime
- •2.3.3 Traditional agriculture
- •2.3.4 Traditional crafts
- •2.3.5 Indigenous cosmologies
- •2.3.6 Traditional music and dance
- •2.3.7 Traditional navigation
- •2.4 Traditional medicine in plant formulations
- •2.4.1 Ayurveda
- •2.4.2 Traditional chinese medicine
- •2.4.3 Indigenous healing practices
- •2.5 Drug discovery
- •2.6 Aspects of developing plant-based drugs
- •2.6.1 Selection criteria for plants
- •2.6.2 Plant material authentication
- •2.6.3 Extraction methods
- •2.6.4 Isolation and structure elucidation of bioactive components
- •2.6.5 Standardization of plant formulations
- •2.7 Conclusions
- •References
- •3. Herbal Healing: Plant-Based Natural Products
- •3.1 Introduction
- •3.2 Classification of secondary metabolites
- •3.2.1 Phenolic compounds
- •3.2.2 Terpenes
- •3.2.3 Alkaloids
- •3.3 History of natural products
- •3.4 Drug discovery from natural products
- •3.5 Drugs derived from the plants
- •3.6 Conclusions
- •Keywords
- •References
- •4. Natural Products with Antimicrobial Properties
- •4.1 Introduction
- •4.2 Plants as antimicrobial agents
- •4.3 Marine sources as antimicrobial agents
- •4.4 Antimicrobial products derived from microorganisms
- •4.5 Conclusions and future trends
- •Keywords
- •References
- •5. Natural Products with Immunomodulatory Properties
- •5.1 Introduction
- •5.2.1 Aloe vera (l.) burm.f. (family: asphodelaceae)
- •5.2.2 Andrographis paniculata (burm. f.) wall.ex.nees. (family: acanthaceae)
- •5.2.3 Acorus calamus l. (family: araceae)
- •5.2.4 Allium sativum l. (family: alliaceae)
- •5.2.5 Azadirachta indica a. juss. (family: meliaceae)
- •5.2.6 Argyreia speciosa (l.f.) sweet (family: convolvulaceae)
- •5.2.7 Bidens pilosa l. (family: asteraceae)
- •5.2.8 Baliospermum montanum (willd.) müll.arg. (family: euphorbiaceae)
- •5.2.9 Boerhaavia diffusa l. (family: nyctaginaceae)
- •5.2.10 Boswellia serrata roxb. excolebr. (family: burseraceae)
- •5.2.11 Camellia sinensis (l.) kuntze (family: theaaceae)
- •5.2.12 Capparis zeylanica l. (family: capparidaceae)
- •5.2.13 Calendula officinalis l. (family: asteraceae)
- •5.2.14 Chelidonium majus l. (family: papaveraceae)
- •5.2.15 Carica papaya l. (family: caricaceae)
- •5.2.26 Glycyrrhiza glabra l. (family: leguminosae)
- •5.2.27 Hypericum perforatum l. (family: hypericaceae)
- •5.2.28 Hippophae rhamnoides l. (family: elaeagnaceae)
- •5.2.29 Hydrastis canadensis l. (family: ranunculaceae)
- •5.2.30 Jatropha curcas l. (family: euphorbiaceae)
- •5.2.31 Mangifera indica l. (family: anacardiaceae)
- •5.2.32 Mollugo verticillata l. (family: molluginaceae)
- •5.2.33 Matricaria chamomilla l. (family: asteraceae)
- •5.2.34 Momordica charantia l. (family: cucurbitaceae)
- •5.2.35 Morinda citrifolia l. (family: rubiaceae)
- •5.2.36 Nigella sativa l. (family: ranunculaceae)
- •5.2.37 Nelumbo nucifera gaertn. (family: nymphaeceae)
- •5.2.38 Nerium oleander l. (family: apocynaceae)
- •5.2.39 Ocimum tenuiflorum l. (family: labiatae)
- •5.2.40 Premna tomentosa willd. (family: verbanaceae)
- •5.2.41 Plantago sp. (plantago major l. and plantago asiatica l.) (family: plantaginaceae)
- •5.2.42 Psoralea corylifolia l. (family: fabaceae)
- •5.2.43 Prunella vulgaris l. (family: lamiaceae)
- •5.2.44 Punica granatum l. (family: punicaceae)
- •5.2.45 Rhinacanthus nasutus (l.) kurz (family: acanthaceae)
- •5.2.46 Salvia officinalis l. (family: lamiaceae)
- •5.2.47 Tamarindus indica l. (family: leguminosae)
- •5.2.48 Tinospora cordifolia (willd.) miers (family: menispermaceae)
- •5.2.16 Centella asiatica (l.) urb. (family: umbelliferae)
- •5.2.17 Cichorium intybus l. (family: asteraceae)
- •5.2.18 Cryptolepis dubia (burm.f.) m.r. almeida (family: apocynaceae)
- •5.2.19 Citrus aurantiifolia (christm.) swingle (family: rutaceae)
- •5.2.20 Curcuma longa l. (family: zingiberaceae)
- •5.2.21 Desmodium gangeticum (l.) dc. (family: fabaceae)
- •5.2.22 Eclipta prostrata (l.) (family: asteraceae)
- •5.2.23 Phyllanthus emblica l. (family: euphorbiaceae)
- •5.2.24 Evolvulus alsinoides (l.) (family: convolvulaceae)
- •5.2.25 Ficus benghalensis l. (family: moraceae)
- •5.2.49 Terminalia chebula retz. (family: combretaceae)
- •5.2.51 Urtica dioica l. (family: urticaceae)
- •5.2.52 Withania somnifera (l.) dunal (cultivated var.) (family: solanaceae)
- •5.3 Traditional importance of research to society and researchers
- •5.4 Conclusion
- •Keywords
- •References
- •6. Natural Products with Anticancerous Properties
- •6.1 Introduction
- •6.2 Plant-derived anticancer compounds
- •6.2.1 Polyphenols
- •6.2.2 Flavanoids
- •6.2.3 Brassinosteroids
- •6.2.4 Vinca alkaloids
- •6.2.5 Taxanes
- •6.2.6 Campothecin derivatives
- •6.3 Microorganisms-based anticancer compounds
- •6.3.1 Primary metabolites
- •6.3.2 Secondary metabolites
- •6.4 Selected medicinal plants with anticancerous activities
- •6.4.1 Curcuma longa l.
- •6.4.2 Viscum album l.
- •6.4.3 Colchicum autumnale l.
- •6.4.4 Raphanus sativus l.
- •6.4.5 Tinospora cordifolia wild
- •6.4.6 Nigella sativa l.
- •6.5 Therapeutic enzymes
- •6.6 Future perspective
- •6.7 Conclusion
- •Keywords
- •References
- •7. Natural Products with Antiviral Properties
- •7.1 Introduction
- •7.2 Source of natural products with antiviral activity
- •7.3 Main components of natural products
- •7.3.1 Flavonoids
- •7.3.2 Polyphenols
- •7.3.3 Polysaccharides
- •7.3.4 Terpenoids
- •7.4 Mechanisms of action of natural compounds in viral infections
- •7.4.1 Direct antiviral effect
- •7.4.2 Anti-inflammatory effect in viral infections
- •7.4.3 Effect on autophagy process
- •7.6 Conclusions
- •Keywords
- •References
- •8. Approaches to Develop Drugs from Natural Products
- •8.1 Introduction
- •8.2 Scenario of drug discovery
- •8.3 Efficient drug discovery engines
- •8.4 Drug discovery approaches using plants
- •8.4.1 Plant selection for screening purpose
- •8.4.2 Authentication of plants
- •8.4.3 Types of molecular markers
- •8.5.1 Parallel approach
- •8.5.2 Sequential approach
- •8.6 Structure elucidation of isolated compounds
- •8.7 Biological screening of extracts/fraction/isolates
- •8.7.1 Cell culture-based assay
- •8.7.2 Dialysis
- •8.7.3 Microdialysis
- •8.7.4 Ultrafiltration
- •8.7.5 Chromatography
- •8.7.6 Ligand fishing
- •8.8 Limitations
- •8.9 Molecular modelling and np database
- •8.10 Future thrust
- •8.11 Conclusion
- •Keywords
- •References
- •9. Strategies for Isolation and Identification of Bioactive Molecules from Natural Sources
- •9.1 Introduction
- •9.2 Bioactive compounds in natural sources and their pharmacological properties
- •9.3.1 Selection of materials
- •9.3.3 Types and properties of solvent for extraction
- •9.4 Extraction methods (conventional and modern)
- •9.4.1 Conventional methods
- •9.4.2 Novel extraction methods
- •9.5 Concentration and purification of bioactive molecules using chromatographic techniques
- •9.5.1 Separation based on adsorption properties
- •9.5.2 Separation based on partition coefficient
- •9.5.3 Separation based on the molecular size
- •9.5.4 Separation based on ionic strength
- •9.5.5 Other modern separation techniques
- •9.6 Identification and characterization of bioactive molecules
- •9.6.1 Qualitative and quantitative techniques/chromatographic or nonchromatographic techniques
- •9.7 Conclusions
- •Keywords
- •References
- •10. Role of Omics in Natural Product-Based Drug Discovery
- •10.1 Introduction
- •10.2 Genomics and transcriptomics in natural product discovery
- •10.2.1 Case studies and examples of natural product discovery using genomics and transcriptomics
- •10.2.2 Limitations and challenges of using genomics and transcriptomics in natural product discovery
- •10.3 Proteomics and metabolomics in natural product discovery
- •10.3.1 Case studies and examples of natural product discovery using proteomics and metabolomics
- •10.4 Bioinformatics in natural product-based drug discovery
- •10.4.1 Role of bioinformatics in natural product-based drug discovery
- •10.4.2 The use of bioinformatics to predict and annotate natural product biosynthetic pathways, gene clusters, and metabolomics
- •10.7 Future perspectives and potential impact of omics in natural product-based drug discovery
- •10.9 Potential impact on drug discovery and development
- •10.10 Conclusion
- •Keywords
- •References
- •11. Natural Products from Endophytic Microorganisms
- •11.1 Introduction
- •11.1.1 Rational/why endophytes?
- •11.2 Diversity of endophytic microorganisms
- •11.2.1 Endophytic bacteria and endophytic actinomycetes
- •11.2.2 Endophytic fungi
- •11.3.1 ISolation methods
- •11.3.1.1.1 Dilution Plating
- •11.3.1.1.2 Direct Plating
- •11.3.2 Identification methods
- •11.4 Bioactive compounds from endophytic microorganisms
- •11.4.1 Antibiotics
- •11.4.2 Antifungal agents
- •11.4.3 Antimalarial agents
- •11.4.4 Antiviral agents
- •11.4.5 Anticancer agents
- •11.4.6 Antioxidants
- •11.5 Stepwise methods for natural product discovery from endophytic microorganisms
- •11.5.1 Plant selection rationale
- •11.5.2 Isolation and cultivation of endophytes
- •11.5.3 Characterization of endophytes
- •11.5.4 Extraction of natural products
- •11.5.5 Purification of natural products
- •11.6 Biosynthesis and strategies for the optimization of natural product discovery from endophytic microorganisms
- •11.6.1 Exploration of novel microbial sources
- •11.6.2 Metabolomics-guided discovery
- •11.6.3 Coculture
- •11.6.4 Genome mining
- •11.6.5 Modulation by ultraviolent irradiation
- •11.7 Future directions and challenges
- •11.7.1 Improving the efficiency and accuracy of screening methods
- •11.7.2 Enhancing the scalability and affordability of production methods
- •11.7.3 Ensure natural product safety and efficacy
- •11.8 Conclusions
- •References
- •12. Natural Products with Antidiabetic Properties
- •12.1 Introduction
- •12.2 Natural products that regulate glucose absorption
- •12.2.1 Serotonin-derived products
- •12.2.2 Butyl-isobutyl-phthalate from laminaria japonica
- •12.2.3 Bioactive compounds of allium cepa and allium sativum
- •12.2.4 Elatosides E and F of aralia elata
- •12.2.5 Bioactive compounds of bauhinia candicans and bauhinia forficate
- •12.3 Natural products that enhance insulin sensitivity
- •12.3.1 Astragalus membranaceus polysaccharides
- •12.3.2 Bioactive compounds of litchi chinensis
- •12.3.3 Bioactive compounds of fenugreek
- •12.3.4 Bioactive compounds of cinnamon
- •12.3.5 Bioactive compounds of gastrodia elata
- •12.3.6 Polysaccharides of dioscorea
- •12.3.7 Anthocyanins of blueberries
- •12.3.8 Bioactive compounds of psidium guajava
- •12.4.1 Gingerol from zingiber officinale
- •12.4.2 Curcumin from curcuma longa
- •12.4.3 Berberine
- •12.4.4 Capsaicin of pepper
- •12.4.5 Bioactive compounds of bitter melon
- •12.4.6 Ginsenosides of ginseng
- •12.4.7 Bioactive compounds of aloe vera
- •12.4.8 Quinides of coffee
- •12.4.9 Bioactive compounds of tinospora cordifolia
- •12.4.10 Bioactive compounds of pterocarpus marsupium
- •12.4.11 Eugenol of ocimum sanctum
- •12.4.12 Bioactive compounds of syzygium densiflorum
- •12.5 Clinical trials based on antidiabetic effects of natural products derived from plants
- •12.5.1 Gymnema sylvestre (gurmar)
- •12.5.2 Fenugreek (trigonella foenum-graecum)
- •12.5.3 Tea catechins
- •12.5.4 Coffee
- •12.5.5 Rosemary (rosmarinus officinalis)
- •12.6 Conclusion
- •12.7 Future scope
- •Keywords
- •References
- •13. Marine-Derived Natural Products with Anticancer Properties
- •13.1 Introduction
- •13.2 Marine bioactive compounds
- •13.3 Anticancer activity of marine plants
- •13.4 Anticancer agents from marine floras
- •13.5.1 Antioxidants
- •13.5.2 Immunomodulation and apoptosis
- •13.5.3 Nutritional values and anticancer effects
- •13.6 Nature and cancer chemotherapy
- •13.7 Marine organisms and cancer chemotherapy
- •13.8 Anticancer agents from marine floras
- •13.9 Marine plants
- •13.9.1 Macro algae (seaweed)
- •13.9.2 Mangroves and other higher plants
- •13.9.3 Cyanobacteria
- •13.9.4 Bacteria
- •13.9.5 Proteobacteria
- •13.9.6 Cyanobacteria
- •13.9.7 Actinomycetes
- •13.9.8 Marine fungi
- •13.9.9 Soft corals
- •13.9.10 Marine sponges
- •13.10 Anticancer bioactive antibiotics derived from marine sources
- •13.10.1 Polyphenols
- •13.10.2 Polysaccharides
- •13.10.3 Alkaloids
- •13.11 Other marine sources for anticancer compounds
- •13.11.1 Peptides
- •13.11.2 Plitidepsin
- •13.11.3 Trabectedin
- •13.11.4 Lurbinectedin
- •13.12 Marine natural products as anticancer drugs
- •13.13.1 Aquaculture/cultivation
- •13.13.2 Genetic engineering
- •13.13.3 Synthesis/semisynthesis/modification
- •13.14 Conclusions and future prospects
- •References
- •14. Natural Products as Novel Opportunities for Cathepsin Inhibitors
- •14.1 Introduction
- •14.2 Cysteine proteases (CPs)
- •14.2.1 Cathepsin
- •14.2.2 Structure and mechanism of action of cathepsins
- •14.3 NPs as cathepsins inhibitors
- •14.3.1 NPs From bacteria as cathepsin inhibitors
- •14.3.2 NPs from fungus as cathepsin inhibitors
- •14.3.3 NPs from marine organism as cathepsin inhibitors
- •14.3.4 NPs from plants as cathepsin inhibitors
- •14.4 Conclusion and future pespectives
- •Keywords
- •References
- •15. Phytoestrogens in Drug Discovery: A Focus on Mechanisms of Action and Safety Assessment
- •15.1 Introduction
- •15.2 Phytoestrogens and estrogen receptors
- •15.3 Nonestrogen receptor-mediated effects of phytoestrogens
- •15.3.1 Mitogen-activated protein kinase (MAPK) pathway
- •15.3.2 PI3K/AKT pathway
- •15.3.3 WNT pathway
- •15.3.4 G-protein-coupled estrogen receptor (GPER)
- •15.4 Structure–activity relationship (SAR) of phytoestrogens
- •15.4.1 Isoflavones
- •15.4.2 Lignans
- •15.4.3 Coumestans
- •15.4.4 Stilbenes
- •15.4.5 Diarylheptanoids
- •15.5 Comparing potency and efficacy of phytoestrogens on various pathways
- •15.5.1 Potency and efficacy of phytoestrogens on different pathways
- •15.5.2 Possible synergistic effects of phytoestrogens with other drugs
- •15.6 Effects of phytoestrogens on the human organs
- •15.7 Safety Assessment of phytoestrogens
- •15.7.1 Toxicity assays used to evaluate the safety of phytoestrogens
- •15.7.2 Potential adverse effects of phytoestrogens
- •15.8 Case study
- •15.8.1 Vaginal cellular differentiation assay
- •15.8.2 Changes in rat body weight
- •15.8.3 Changes in rats’ uterus weight
- •15.9 Current trends in phytoestrogen research
- •15.9.1 Publication trends
- •15.9.2 Analysis of contributing countries and contributing institutions
- •15.9.3 Analysis of contributing publishers and journals
- •15.9.4 Publication evolution and research areas
- •15.9.5 Limitations
- •15.10 Future directions
- •15.10.1 Exploration of unexplored plant sources
- •15.10.2 Understanding mechanisms of action
- •15.10.3 Synthesis of novel compounds
- •15.10.4 Development of SPERMs
- •15.10.5 Safety assessment
- •15.11 Conclusion
- •Keywords
- •References
- •16. Honey Bee Products with Antimicrobial Properties
- •16.1 Introduction
- •16.2 Honey
- •16.3 Bee bread (perga)
- •16.4 Bee pollen
- •16.5 Bee propolis
- •16.6 Conclusion
- •Keywords
- •References
- •17. Natural Products for the Prevention of Leaky Gut
- •17.1 Introduction
- •17.2 The physical and chemical barriers of the intestine
- •17.2.1 Thick mucus layer
- •17.2.2 Intestinal epithelial cells (IECS)
- •17.2.3 Intestinal junctional complexes
- •17.2.4 Lamina propria
- •17.2.5 Intestinal regulatory T cells
- •17.2.6 Intestinal alkaline phosphatase
- •17.2.7 Antimicrobial peptides
- •17.2.8 Lysozyme
- •17.3 Mechanistic view of factors leading to a leaky gut
- •17.3.1 Gut dysbiosis
- •17.3.2 Mucosal inflammation and oxidative stress
- •17.3.3 TJ disruption
- •17.3.4 Genetics
- •17.3.5 Drugs
- •17.4 Pathological implications of a leaky gut
- •17.5 Natural product improving gut microbial dysbiosis
- •17.5.1 Traditional herbs and polyherbal formulations managing gut micro flora
- •17.5.2 Phytocompounds in the management of intestinal barrier integrity through balancing gut microflora
- •17.6.1 Anti-inflammatory traditional medicine and plant extracts ameliorating intestinal mucosal injury
- •17.6.2 Plant active constituents preventing mucosal injury and oxidative damage
- •17.7 Traditional medicine and natural products upregulating the TJ proteins
- •17.7.1 Traditional medicine and herbal extracts promoting junction protein protection
- •17.7.2 Phytocompounds for junction protein protection
- •17.8 Natural products averting pathological conditions through maintaining intestinal barrier function
- •17.9 Conclusion
- •Keywords
- •References
- •18. Role of Natural Products in the Pharmacotherapy of Osteoporosis
- •18.1 Introduction
- •18.1.1 Effect of traditional chinese medicine (TCM)
- •18.1.2 Effect of malay traditional medicine
- •18.1.3 Antiosteoporotic agents extracted from plant sources
- •18.1.4 Treatment by different pigments
- •18.1.5 Other herbal sources
- •18.1.6 Natural plant-based alkaloids
- •18.1.7 Essential markers involved in bone formation and resorption for osteoporosis treatment
- •18.2 Conclusion
- •Keywords
- •References
- •19. Gel-Based Natural Therapeutics: Potential Alternatives to Traditional Drug Delivery Systems in Aquaculture
- •19.1 INtroduction
- •19.2 DDS
- •19.2.1 Water medication
- •19.3 Oral administration
- •19.3.1 Gavage

CHAPTER 3
Herbal Healing: Plant-Based Natural Products
ANCHAL SHARMA
1
1,*
and MEENAKSHI THAKUR
2
2
*Corresponding author
ABSTRACT
All traditional medical practices, including Ayurveda, Siddha, Unani, yoga, naturopathy,
and homeopathy, are mostly based on the use of plants. For many years, people seek
herbal remedies, conventional therapies, and conventional doctors as the primary source
of healthcare. The World Health Organization estimates that 60% of the world’s population uses herbal medicine and that 80% of those in underdeveloped nations rely entirely
on it for their basic medical requirements. Plant products such as secondary metabolites
are the main constituents of drugs. Compounds that are derived from plants and have
industrial, food, and medical uses are known as plant-derived natural products. Due to
lack of knowledge about plant use and value, many plants are underutilization even those
that have high medicinal value. Hence this study provides valuable information about the
natural compounds of important plants and their medicinal value which will benefit the
development of pharmaceutical products. It will also help to promote the conservation of
these plants due significant medicinal value.
3.1 INTRODUCTION
A variety of natural products are derived from plants with numerous medicinal
characteristics that have always gained overwhelming focus and are being studied to
create new drugs (Singh, 2006). Chemical substances produced by living things and
found in nature are known as natural products. These chemicals are employed in a variety
of industries and applications such as medicines and cosmetics, food, and agricultural
products. Natural products can be found in a variety of sources, including plants, fungi,
bacteria, and even marine organisms. Natural products are often used as ingredients in
food, cosmetics, and drugs due to their therapeutic and medicinal properties.

44
Plants create a wide variety of organic compounds, the majority of which do not seem
to be directly related to growth and development. These organic molecules, also known
as secondary metabolites, are dispersed in a variety of ways across the kingdom of plants.
Secondary metabolism has evolved in response to environmental needs and challenges. Their
functions, many of which are yet unclear, are frequently becoming clearer (Croteau et al.,
2000). A diverse range of natural products is synthesized collectively by plants (Wink,
1999). Plant-derived natural products are compounds that are derived from plants and can
be used for medicinal, industrial, and food applications. Since time immemorial the only
source of medicine is natural products. Traditional medicine, the oldest healthcare form in
the world, uses natural products to cure many diseases and illnesses. The different plants
including herbs, vegetables, spices, fruits, and seeds are the source of plant-based natural
products. Oils, extracts, tinctures, ointments, and powders are the most common forms in
which they are extracted and rened for use. Due to their well-known antibacterial, antiinammatory, and antioxidant qualities, they are helpful for a variety of medical disorders.
3.2 CLASSIFICATION OF SECONDARY METABOLITES
Plant-based natural chemicals have long been a useful source of medicines and continue
to be crucial in developing new medications. Alkaloids, terpenes, and other chemicals, as
well as other natural products with pharmacological activity , are examples of plant-derived
natural products. These substances have a long history of usage as medications and can be
used to treat a wide variety of ailments.
There are around 2,140,000 secondary metabolites known, and they may be divided into
three main classes based on their production processes and structural properties. (1) Phenolic
compounds; (2) Terpenes/Terpenoids; and (3) Nitrogen- and sulfur-containing alkaloids.
3.2.1 PHENOLIC COMPOUNDS
Phenolic compounds are byproducts of the metabolism of phenylpropanoid in pentose
phosphate and plant shikimic acid (Randhir et al., 2004). They range in complexity from
complex phenolic compounds to simple phenolic molecules, but they always have benzene
rings with one or more hydroxyl substituents (Velderrain-Rodríguez et al., 2014). The
binding of glucose to the pentose phosphate pathway and the irreversible transformation
of glucose-6-phosphate into ribulose-5-phosphate are the first steps in the production of
the phenolic molecule (Figure 3.1). Throughout the metabolic process, one can observe
the dispersion of phenolics, which are the most noticeable secondary metabolites in plants
(Lin et al., 2016).
3.2.2 TERPENES
The most well-known terpenes are byproducts of odoriferous plants such as turpentine and
camphor (Figure 3.2). Each and every terpene is composed of a large number of isoprene

45
units, which can be linear, cyclic, saturated, or unsaturated, as well as altered in a variety
of ways (Keller et al., 2005).
FIGURE 3.1 Types of phenolic compounds.
FIGURE 3.2 Types of terpenes.
⏎
⏎

46
3.2.3 ALKALOIDS
About 20% of the known secondary metabolites discovered in plants are alkaloids (Chik
et al., 2013). Initially, Alkaloids are believed to play the role of nitrogen storage in plants.
But various researches show that alkaloids in plants defend against predators and control
growth. Alkaloids are particularly well known for their therapeutic uses as anesthetics,
cardioprotective, and anti-inflammatory drugs (Figure 3.3). Among the well-known
alkaloids used in clinical settings are nicotine, ephedrine, strychnine, quinine, and quinine
(Kurek, 2019).
FIGURE 3.3 Types of alkaloids.
⏎
3.3 HISTORY OF NATURAL PRODUCTS
The history of drug discovery began in 1803, with the separation of morphine from Papaver
somniferum, the first plant-derived drug (Krishnamurti and Rao, 2016). A total of 70,000
herbal plants, mostly in Asian pharmaceuticals, have been employed for medical reasons.
Overall 20% of plant species in India are utilized medicinally . These healing plants contain
a vast storehouse of ethnobotanical chemicals that are used in numerous medicine drug
carriers today.
Since ancient times, natural products originating from plants have been employed
in both traditional and modern medicines for the treatment of a wide range of diseases,
such as Cancer, Malaria, Cardiovascular, Alzheimer, etc. (Balunas and Kinghorn, 2005;
et al., 2016; Wangchuk, 2018). Cupressus and Commiphora species were utilized
Yuan

47
by Mesopotamians as far back as 2600 BC and are still employed for this purpose to treat
inammation, coughs, and colds. Plant-derived crude drugs or crude extracts contain a
variety of complex compounds that possess therapeutic properties. Since 1632, cinchona
tree bark extract has been used to treat malaria; nevertheless, it was not until 1820 that
the pure antimalarial drug quinine became the rst chemical employed in contemporary
medicine to treat an infectious disease (Achan et al., 2011). Furthermore, the synthetic
pharmaceutical industry was initiated with the manufacturing of aspirin serving as a manmade equivalent of salicylic acid, which was initially isolated from a willow tree in 1897
(Landau, 2010). Today, natural products derived from plants continue to be an important
source of medicines and drugs. The World Health Organization estimates that at least 25%
of medicines recommended in afuent nations come from organic sources such as plants,
animals, and microbes (World Health Organization, 2013). Additionally, the “wonder
drug” theories that claim a single medication can treat all diseases and all people must be
revised. With many molecules remaining to be found, nature already provides possibilities
for medication research. Nature has already produced a number of medications, including
Taxol (Taxus brevifolia) and antimalarial medications like quinine (Cinchona spp.) and
Artemisinin (Artemisia annua) (Thomford et al., 2018). Over a long period of time, humans
have understood that plants are a good source of medicine (Lietava, 1992).
Natural products derived from plants have been used in traditional medicine for
thousands of years. Ancient healers and shamans used medicinal plants to treat a variety of
ailments and diseases. For example, Hippocrates (460–370 BC), the “Father of Medicine,”
prescribed plants such as willow bark for pain relief and cinchona bark for the treatment
of malaria (Smulyan, 2018). In the 19th century, the eld of natural product chemistry
was established, as chemists began to isolate and identify active compounds from
medicinal plants. Aspirin, for example, was rst isolated from willow bark in 1829 by
Henri Leroux, and a synthetic form of it was developed by Felix Hoffmann in 1897. Other
notable natural products isolated from plants include caffeine (from coffee beans), quinine
(from cinchona bark), and ephedrine (from the ephedra plant) (Montinari et al., 2019).
The initial successful therapy for malaria was the naturally occurring chemical quinine. In
underdeveloped nations, this is still a common therapy and was the norm up until the 1940s
(Reyburn et al., 2009). The only known naturally occurring source of quinine, the cinchona
tree, was originally discovered to have medicinal properties by the Quechua Indians of
Peru and Bolivia. In the 20th century, advances in chemistry and biotechnology enabled
the synthesis of complex natural molecules such as paclitaxel (from the yew tree) and
artemisinin (from sweet wormwood). These compounds are now used to treat cancer and
malaria, respectively (Desmarchelier, 2010).
3.4 DRUG DISCOVERY FROM NATURAL PRODUCTS
Friedrich Wilhelm Sertürner achieved the isolation of morphine, the first naturally derived
substance to be made commercially available for medicinal purposes. Bayer in 1899 launched
the first semisynthetic, pure drug based on the natural compound salicin was derived from

48
the plant Salix alba. As an outcome of this early drugs including cocaine, codeine, digitoxin,
quinine, and pilocarpine were isolated. Several other recent plant-derived compounds
underwent research and development and were marketed as medicine such as Artemisinin
from the traditional Chinese plant Artemisia annua to fight drug-resistant malaria, Silymarin
from the seeds of Silybum marianum to treat liver conditions, Paclitaxel from T axus br evifolia
to treat lung, ovarian, and breast cancer, and more (Newman et al., 2000).
Natural ingredients are still used as sources of novel structures (Newman and Cragg,
2012). Close to 50% of medications licensed in the last 30 years have been developed
directly or indirectly from natural ingredients. Among the 175 small molecules that have
been used to treat cancer since the 1940s, 85 are either natural products themselves or
directly derived from them.
3.5 DRUGS DERIVED FROM THE PLANTS
A significant range of drugs has been discovered from plant sources that have historically
been used in ethnomedicine or ethnobotany (Table 3.1). In contrast, others have been
discovered after being randomly tested on animals or after being examined for biological
activity in vitro or in vitro (Krause and Tobin, 2013).
3.6 CONCLUSIONS
With advancement of science and technology human being developed the synthetic
compounds, still effective alternative of many natural products are yet to discover. To
meet the high demand and reduce the cost of production naturally occurring compound
are always a best solution. With the advancement of techno logy, our way of life is moving
more away from nature. We cannot escape nature despite the fact that we are a part of it.
Plant-based natural compounds are generally safe, environmentally friendly , and abundant
in nature, making them good candidate for drug discovery and development. They also
have no adverse side effects. Several herbs have been used traditionally to cure ailments
associated with particular seasons.
These herbal medications are now considered as a sign of safety as opposed to synthetic
drugs, which are thought to be harmful to both humans and the environment. The mindless
reliance on synthetics has ended, though, and people are going back to natural products
in the hopes of nding safety and security. Due to the industrial revolution, secondary
metabolites become backbone of the food industries, pharma industries, perfume industries, etc. It is time to promote them worldwide. We are going further away from nature as
our way of life becomes more technologically advanced. But at the same time it is true, that
various plants have long been valued for their ability to treat illness, and they remain one of
the greatest and most efcient sources used to create novel natural-derived chemicals that
have the potential to become top-tier medicines. That is why it is very important to save
plants and natural products derived from them and use them properly.

TABLE 3.1 Details of Plant-Based Drugs Derived from the Different Plant Species
Plant Species Family Class Plant‑based Drugs Medicinal Properties
Aesculus hippocastanum L.
Agrimonias eupatoria
Anabasis aphylla L.
Andrographis paniculata (Burm.f.) Nees
Anisodus tanguticus (Maxim.) Pascher
Areca catechu L.
Artemisia maritime L.
Atropa belladonna L.
Berberis vulgaris L.
Betula alba L.
Brassica
Camellia
Camptotheca acuminata Decne
Carica papaya L.
Cassia angustifolia M Vahl
Catharanthus roseus (L.) G. Don
Centella asiatica (L.) Urb.
Cephaelis ipecacuanha (Brot.) A. Rich.
Chondodendron tomentosum
Cinchona ledgeriana (Howard) Bern.
Moens ex Trimen
Cinnamomum camphora (L.) J. Presl
Cissampelos pareira L.
Colchicum autumnale L.
Coptis japonica (Thunb.) Makino Ranunculaceae
Corydalis ambigua Cham. & Schltdl.
nigra (L.) K. Koch
sinensis (L.) Kuntze
Sapindaceae Terpene Aescin Anti-inflammatory
Rosaceae Carboxylic ester Agrimophol Anthelmintic
Amaranthaceae Alkaloids Anabesine Skeletal muscle relaxant
Acanthaceae Terpene Andrographolide, Neoandrographolide Baccillary dysentery
Solanaceae Alkaloids Anisodamine, Anisodine Anticholinergic
Arecaceae Alkaloids Arecoline Anthelmintic
Asteraceae Santonin Ascaricide
Solanaceae Alkaloids Atropine Anticholinergic,
Berberidaceae Alkaloids Berberine Bacillary dysentery
Betulaceae Terpene Betulinicacid Anticancer
Brassicaceae Allylisothiocyanate Rubefacient
Theaceae Alkaloids Caffeine CNS stimulant
Nyssaceae Alkaloids Camptothecin, Irinotecan, T opotecan Anticancer
Caricaceae Alkaloids Chymopapain, Danthron Papain, Sennosides A, B Proteolytic, mucolytic,
Caesalpinaceae Alkaloids Senna Laxative
Apocynaceae Alkaloids Vinblastine, Vinblastine, V asicine, Vinorelbine,
Apiaceae Terpene Asiaticoside Vulnerary
Rubiaceae Alkaloids Emetine Amoebicide, emetic
Menispermaceae Alkaloids Tubocurarine Skeletal muscle relaxant
Rubiaceae Alkaloids Quinidine, Quinine Antimalarial, antipyretic,
Lauraceae Terpene Camphor Rubefacient
Menispermaceae Alkaloids Cissampeline Skeletal muscle relaxant
Colchicaceae Alkaloids Demecolcine, Colchicine, Antitumoragent, anti-gout
Alkaloids Palmatine Antipyretic, detoxicant
Papaveraceae Alkaloids Tetrahydropalmatine Analgesic, sedative,
⏎
Vindesine, Vinflunine
painkiller
laxative
Anticancer, antileukemic
agent, cerebral stimulant
antiarrhythmic
traquillizer
49

TABLE 3.1
Plant Species Family Class Plant‑based Drugs Medicinal Properties
Curcuma longa L. Zingiberaceae
Datura stramonium L.
Digitalis lanata Ehrh.
Digitalis purpurea L.
Erythroxylum coca Lam.
Ephedra sinica Stapf
Erythroxylum coca Lam.
Fraxinus rhynchophylla Hance
Gaultheria procumbens L.
Glaucium flavum Crantz
Glycyrrhiza glabra L. Fabaceae
Gossypium sp.
Hemsleya amabilis Diels
Hydrastis canadensis L.
Hyoscyamus niger L.
Larrea divaricata Cav.
Lobelia inflata L.
Lycoris squamigera Maxim.
Maclura pomifera (Raf.) C.K. Schneid
Mentha viridis (L.) L.
Mucuna pruriens (L.) DC.
Nicotiana tabacum L.
Nothapodytes foetida (Wight) Sleumer
Ocotea glaziovii Mez
Perilla frutescens L. Britton var. Crispa
(Continued)
Terpene Curcumin Choleretic
Solanaceae Alkaloids Scopolamine Sedative
Plantaginaceae Steroids Lanatosides, Deslanoside, Acetyldigoxin Cardiotonic glycosides
Plantaginaceae Steroids Gitalin, Digoxin, Digitalin, Digitoxin Cardiotonic
Erythroxylaceae Alkaloids Cocaine Anti-gout
Ephedraceae Alkaloids Ephedrine, Pseudoephredrine Sympathomimetic,
antihistamine
Erythroxylaceae Alkaloids Cocaine Local anaesthetic
Oleaceae Phenolic acid Aesculetin Anti-dysentery
Ericaceae Alkaloids Methylsalicylate Rubefacient
Papaveraceae Alkaloids Glaucine Antitussive
Terpene Glycyrrhizin Sweetener, Addison’ s
disease
Malvaceae Polyphenol Gossypol Male contraceptive
Cucurbitaceae Terpene Hemsleyadin Bacillary dysentery
Ranunculaceae Alkaloids Hydrastine Hemostatic, astringent
Solanaceae Alkaloids Hyoscyamine Anticholinergic
Zygophyllaceae Phenolic acid Nordihydroguaiaretic acid Antioxidant
Campanulaceae Alkaloids α-Lobeline Smoking deterrant,
respiratory stimulant
Amaryllidaceae Alkaloids Alkaloids Cholinesterase inhibitor
Moraceae Phenolic acid Phenolic acid Anticancer
Lamiaceae Terpene Terpene Rubefacient
Fabaceae Phenolic acid Phenolic acid Anti-parkinsonism
Solanaceae Alkaloids Nicotine Insecticide
Stemonuraceae Alkaloids Camptothecin Anticancer
Lauraceae Alkaloids Glasiovine Antidepressant
Lamiaceae Terpenes
9-OH-isoegomaketone [(2E)-1-(3-furanyl)
-4-OH-4-Me-2-penten-1-one
50

TABLE 3.1
Plant Species Family Class Plant‑based Drugs Medicinal Properties
Papaver somniferum L.
Pausinystalia yohimba Pierre ex Beille
Physostigma venenosum Balf.
Pilocarpus jaborandi Holmes Rutaceae
Potentilla fragarioides Cham. & Schltdl.
Rauvolfia canescens L.
Salix alba L.
Sanguinaria canadensis L.
Silybum marianum (L.)
Simarouba glauca DC.
Sophora pachycarpa C.A. Mey
Stephania sinica Diels Menispermaceae
Stephania tetrandra S. Moore Menispermaceae
Strophanthus gratus (Wall. & Hook.) Baill.
Strychnos nux-vomica
Strychnos toxifera R. H. Schomb. ex Lindl.
Taxus brevifolia Nutt.
Theobroma cacao L.
Urginea maritima (Thunb.) Baker
Valeriana officinalis L.
Veratrum album L.
Vanilla planifolia Jacks. Ex Andrews
References: Balandrin
(Continued)
et al. (1993); Reddy (2017)
Papaveraceae Alkaloids Papavarine, Noscapine, Codeine, Morphine Analgesic, antitussive,
smooth muscle relaxant
Rubiaceae Alkaloids Yohimbine Aphrodisiac
Fabaceae
Rosaceae Phenolic acid (+)-Catechin Haemostatic
Apocynaceae Alkaloids Deserpidine Antihypertensive,
Salicaceae Terpene Salicin Analgesic
Papaveraceae Alkaloids Sanguinarine Dental plaque inhibitor
Asteraceae Phenolic acid Silymarin Antihepatotoxic
Simaroubaceae Terpene Glaucarubin Amoebicide
Fabaceae Alkaloids Pachycarpine Oxytocic
Apocynaceae Alkaloids Ouabain Cardiotonic
Loganiaceae Alkaloids Strychnine CNS stimulant
Loganiaceae Alkaloids Curare, D-tubocurarine Muscle relaxant
Taxaceae Alkaloid Taxol Antitumor agent
Malvaceae Alkaloids Theobromine Diuretic, vasodilator
Asparagaceae Steroid/Alkaloids Scillarin A Cardiotonic
Caprifoliaceae Terpene Valapotriates Sedative
Melanthiaceae Alkaloids Protoveratrines A, B Antihypertensives
Orchidaceae Phenolic acid Vanillin Antioxidant, antimutagenic
Alkaloid Physostigmine Cholinesterase inhibitor
Alkaloid Pilocarpine Parasympathomimetic
(Cholinergic)
tranquillizer
Alkaloids Rotundine Analagesic, sedative,
traquillizer
Alkaloids Tetrandrine Antihypertensive
51

52
KEYWORDS
• herbal medicine
• natural products
• phenolic compounds
• natural-derived chemicals
• secondary metabolites
REFERENCES
Achan, J.; T alisuna, A. O.; Erhart, A.; Yeka, A.; Tibenderana, J. K.; Baliraine, F . N.; Rosenthal, P . J.; D’Alessandro,
U. Quinine, an old anti-malarial drug in a modern world: Role in the treatment of malaria. Malaria J. 2011,
10(1), 1–12.
Balandrin, M. F.; Kinghorn, A. D.; Farnsworth, N. R. Plant-derived natural products in drug discovery and
development: An overview. 1993. doi: 10.1021/bk-1993-0534.ch001
Balunas, M. J.; Kinghorn, A. D. Drug discovery from medicinal plants. Life Sci. 2005, 78(5), 431–441.
Chik, S. C.; Or, T. C.; Luo, D.; Yang, C. L.; Lau, A. S. Pharmacological effects of active compounds on
neurodegenerative disease with gastrodia and uncaria decoction, a commonly used poststroke decoction. Sci.
World J. 2013, 2013, 896873.
Croteau, R.; Kutchan, T . M.; Lewis, N. G. Natural products (secondary metabolites). Biochem. Mol. Biol. Plants.
2000, 24, 1250–1319.
Desmarchelier, C. Neotropics and natural ingredients for pharmaceuticals: Why isn’ t South American biodiversity
on the crest of the wave? Phytother. Res. 2010, 24(6), 791–799.
Keller, N. P.; Turner, G.; Bennett, J. W. Fungal secondary metabolism—from biochemistry to genomics. Nat.
Rev. Microbiol. 2005, 3(12), 937–947.
Krause, J.; T obin, G. Discovery, development and regulation of natural products. In: Kulka, M. (Ed.), Using Old
Solutions to New Problems—Natural Drug Discovery in the 21 Century. InTech Publishers. 2013, pp. 3–35.
Krishnamurti, C.; Rao, S. C. The isolation of morphine by Serturner. Indian J. Anaesth. 2016, 60(11), 861.
Kurek, J. (Ed.). Alkaloids: Their Importance in Nature and Human Life. BoD–Books on Demand. 2019.
Landau, E. From a tree, a “Miracle” called aspirin. CNN Health: Matters of the Heart. 2010.
Lietava, J. Medicinal plants in a middle paleolithic grave ShanidarIV . J. Ethnopharmacol. 1992, 35(3), 263–266.
Lin, D.; Xiao, M.; Zhao, J.; Li, Z.; Xing, B.; Li, X.; ... Chen, S. An overview of plant phenolic compounds and
their importance in human nutrition and management of type 2 diabetes. Molecules. 2016, 21(10), 1374.
Montinari, M. R.; Minelli, S.; De Caterina, R. The first 3500 years of aspirin history from its roots—a concise
summary. Vascul. Pharmacol. 2019, 113, 1–8.
Newman, D. J.; Cragg, G. M. Natural products as sources of new drugs over the 30 years from 1981 to 2010.
J. Nat. Prod. 2012, 75(3), 311–335.
Newman, D. J.; Cragg, G. M.; Snader, K. M. The influence of natural products upon drug discovery. Nat. Prod.
Rep. 2000, 17(3), 215–234.
Randhir, R.; Lin, Y. T.; Shetty, K. Stimulation of phenolics, antioxidant and antimicrobial activities in dark
germinated mung bean sprouts in response to peptide and phytochemical elicitors. Proc. Biochem. 2004, 39(5),
637–646.
Reddy, J. Important medicinal plant families and plant based drugs: A review . In: Proceeding 5th International
Conference on Civil, Architecture, Environment and Waste Management (CAEWM-17), 2017, Singapore,
March (pp. 29–30).
Соседние файлы в папке Библиотека им академика М.И. Перельмана
